Addiction Research

According to the World Health Organization (WHO), addiction is 'a chronic disease of the central nervous system that is characterized by a loss of control over impulsive behavior that leads to compulsive drug seeking and taking, and to relapses even after months of abstinence'. Addiction is a complex neuroadaptive process, where drugs of abuse alter cellular and molecular aspects of neural function. The brain circuits mediating the various behavioral effects of these drugs are rendered more, or less, responsive to those effects.

Addiction Research Products Targets

Products for Addiction Research - Page 11

Cat.No. Product Name Information/Activity
BCC6681 8-Hydroxy-DPAT hydrobromide 76135-31-4
BCC6266 LP 20 hydrochloride 1386928-34-2
BCC7705 3-Bromocytisine 3-Bromocytisine (3-Br-cytisine) is a potent nACh receptors agonist, with IC50s are 0.28, 0.30 and 31.6 nM for hα4β4, hα4β2, and hα7-nACh, respectively. 3-Bromocytisine (3-Br-cytisine) shows different effects on high (HS) and low (LS) ACh sensitivity α4β2 nAChRs with EC50s are 8 and 50 nM, respectively.
BCC7099 5-Iodo-A-85380 dihydrochloride 1217837-17-6
BCC7102 5-Iodo-A-85380, 5-trimethylstannyl N-BOC derivative 213766-21-3
BCC3821 Nicotine Difartrate 65-31-6
BCC6118 3-pyr-Cytisine 948027-43-8
BCC1902 RJR-2403 oxalate Rivanicline oxalate (RJR-2403 oxalate; (E)-Metanicotine oxalate) is a neuronal nicotinic receptor agonist, showing high selectivity for the α4β2 subtype (Ki=26 nM); > 1,000 fold selectivity than α7 receptors(Ki= 3.6 μM).
BCC7975 SIB 1508Y maleate 192231-16-6
BCC7469 TC 2559 difumarate 212332-35-9